Cellular 'groundskeeper' considered in cancer fight

July 30, 2014 by Rob Payne, Science Network WA
"Autophagy is an area that potentially could make a difference in patient care and aid in the development of more effective cancer treatment," Prof Dass says. Credit: Polygon Medical Animation

A greater focus on autophagic activity and metabolism in cancerous cells could make a significant difference in the development of more effective cancer treatments, researchers contend.

Functioning as a sort of cellular groundskeeper, autophagy helps remove damaged proteins or organelles, facilitating their degradation into recyclable molecules to be released into the cytoplasm for re-use by the cell.

A catabolic process, autophagy has been linked to cancer prevention, clearing out damaged materials and promoting homeostasis (stable equilibrium between elements).

But, it has also been implicated in aiding the survival of established tumours, responding to metabolic stress to create pathways for cells to persist in cytotoxic and hypoxic conditions.

This downside has led previous researchers to focus on its role in chemotherapy and anti-cancer drug resistance.

However, Curtin University School of Pharmacy and Biosciences Research Precinct Professor Crispin Dass says understanding autophagy's dual nature is vital.

"The idea of metabolism as a target for cancer therapy is not new but was previously put aside due to the opinion that its use would be more deleterious than beneficial," he says.

"With the advances in the knowledge of the exact mechanisms and pathways involved in metabolic function, the proposal of metabolism as a target is becoming more feasible given that it can now be targeted to transformed cells, including indirectly through interactive pathways such as autophagy.

"This highlights the need to continue to pursue research into autophagy, in an attempt to truly understand its role in various cell lines and identify the variations in response to alternative stimulus."

Autophagy crucial for future treatment

Prof Dass says that without an increased focus on autophagy, and an understanding of its molecular mechanisms, significant improvements to current and future chemotherapeutic treatment may be unlikely.

"Autophagy is an area that potentially could make a difference in patient care and aid in the development of more effective ," he says.

"In an area of research where a clear majority of benchwork is devoted to finding new targets and subsequently, drugs to target these, a relook at the way the traditional drugs induce cell death in tumours may pave the way to better clinical management of this class of disease."

He says another research area of interest is exploring how such as nanoparticles made of biodegradable and 'green' resource materials can induce cell biological events in cells, including .

Explore further: Discovery of protein that regulates cellular recycling yields new drug targets

Related Stories

Discovery of protein that regulates cellular recycling yields new drug targets

June 2, 2014
Researchers at the University of Michigan have discovered a key regulator of autophagy, the cellular recycling process involved in many human diseases. The finding illuminates potential new drug targets for cancer, neurodegeneration ...

Zombie cancer cells eat themselves to live

April 5, 2014
A University of Colorado Cancer Center study recently published in the journal Cell Reports and presented today at the American Association for Cancer Research (AACR) Annual Conference 2014 shows that the cellular process ...

Acidic tumour pH inhibits drug effect

February 11, 2014
Low pH in tumours counteracts the desired effect of the drug chloroquine, according to a new study from Karolinska Institutet in Sweden. The results, which are published in the journal Autophagy, might explain possible lack ...

Autophagy predicts which cancer cells live and die when faced with anti-cancer drugs

January 10, 2014
(Medical Xpress)—When a tumor is treated with an anti-cancer drug, some cells die and, unfortunately, some cells tend to live. A University of Colorado Cancer Center study published in the journal Nature Cell Biology details ...

Improved effectiveness of chemotherapy for cancer

August 15, 2013
Cancer cells often develop defence mechanisms which enable them to survive chemotherapy. A group of researchers from the Institutes of Pharmacology and Pathology in Bern present new solutions for preventing the development ...

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.